USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Sensébeautiful science products, such as personal care products that support healthy skin and hair through topical nourishment, moisturization, and protection; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Industry, Sector and Symbol
Industry Medicinals & botanicals
Sub-IndustryPersonal Products
SectorMedical
Phone801-954-7100
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.05 billion
Profitability
Miscellaneous
Employees1,810
OptionableOptionable
USANA Health Sciences (NYSE:USNA) Frequently Asked Questions
What is USANA Health Sciences' stock symbol?
USANA Health Sciences trades on the New York Stock Exchange (NYSE) under the ticker symbol "USNA."
How will USANA Health Sciences' stock buyback program work?
USANA Health Sciences announced that its Board of Directors has approved a stock repurchase program on Tuesday, October 23rd 2018, which authorizes the company to repurchase $150,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to reacquire up to 5.9% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company's board believes its stock is undervalued.
How were USANA Health Sciences' earnings last quarter?
USANA Health Sciences, Inc. (NYSE:USNA) issued its quarterly earnings results on Tuesday, October, 23rd. The company reported $1.24 EPS for the quarter, beating the consensus estimate of $1.10 by $0.14. The firm had revenue of $296.80 million for the quarter, compared to analysts' expectations of $289.54 million. USANA Health Sciences had a net margin of 7.57% and a return on equity of 29.67%. The business's quarterly revenue was up 13.4% compared to the same quarter last year. During the same period last year, the firm posted $1.03 EPS. View USANA Health Sciences' Earnings History.
When is USANA Health Sciences' next earnings date?
How can I listen to USANA Health Sciences' earnings call?
USANA Health Sciences will be holding an earnings conference call on Wednesday, February 6th at 11:00 AM Eastern. Interested parties can register for or listen to the call using this link.
What price target have analysts set for USNA?
2 brokerages have issued twelve-month price objectives for USANA Health Sciences' shares. Their predictions range from $135.00 to $135.00. On average, they expect USANA Health Sciences' share price to reach $135.00 in the next year. This suggests a possible upside of 14.2% from the stock's current price. View Analyst Price Targets for USANA Health Sciences.
What is the consensus analysts' recommendation for USANA Health Sciences?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for USANA Health Sciences in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for USANA Health Sciences.
Has USANA Health Sciences been receiving favorable news coverage?
News coverage about USNA stock has been trending very positive on Tuesday, InfoTrie reports. The research firm identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. USANA Health Sciences earned a news sentiment score of 3.2 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 4.0 out of 10, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.
Who are some of USANA Health Sciences' key competitors?
Some companies that are related to USANA Health Sciences include Canopy Growth (CGC), Tilray (TLRY), Aurora Cannabis (ACB), STADA Arzneimittel (STDAF), Cronos Group (CRON), Foamix Pharmaceuticals (FOMX), Chromadex (CDXC), Mediwound (MDWD), Natural Alternatives International (NAII), China Jo-Jo Drugstores (CJJD), Mannatech (MTEX), Pharmacyte Biotech (PMCB), GLG Life Tech (GLGLF), Cyanotech (CYAN) and FitLife Brands (FTLF).
Who are USANA Health Sciences' key executives?
USANA Health Sciences' management team includes the folowing people:
- Dr. Myron W. Wentz, Founder & Chairman (Age 78)
- Mr. Kevin G. Guest, CEO & Director (Age 56)
- Mr. Jim Brown, Pres & COO (Age 50)
- Mr. G. Douglas Hekking, Chief Financial Officer (Age 49)
- Mr. Daniel A. Macuga Jr., Chief Communications & Marketing Officer (Age 49)
Who are USANA Health Sciences' major shareholders?
USANA Health Sciences' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Bowling Portfolio Management LLC (0.05%). Company insiders that own USANA Health Sciences stock include Daniel A Macuga, David Mulham Mulham, Feng Peng, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, James Bramble, Jim Brown, Joshua Foukas, Kevin Guest, Myron W Wentz, Paul A Jones, Robert A Sinnott and Walter Noot. View Institutional Ownership Trends for USANA Health Sciences.
Which institutional investors are selling USANA Health Sciences stock?
USNA stock was sold by a variety of institutional investors in the last quarter, including Bowling Portfolio Management LLC. Company insiders that have sold USANA Health Sciences company stock in the last year include Daniel A Macuga, David Mulham Mulham, Feng Peng, Frederic J Winssinger, G Doug Iiekking, Gilbert A Fuller, Global Ltd Gull, Jim Brown, Joshua Foukas, Kevin Guest, Myron W Wentz, Paul A Jones, Robert A Sinnott and Walter Noot. View Insider Buying and Selling for USANA Health Sciences.
How do I buy shares of USANA Health Sciences?
Shares of USNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is USANA Health Sciences' stock price today?
One share of USNA stock can currently be purchased for approximately $118.25.
How big of a company is USANA Health Sciences?
USANA Health Sciences has a market capitalization of $2.85 billion and generates $1.05 billion in revenue each year. The company earns $62.53 million in net income (profit) each year or $4.06 on an earnings per share basis. USANA Health Sciences employs 1,810 workers across the globe.
What is USANA Health Sciences' official website?
How can I contact USANA Health Sciences?
USANA Health Sciences' mailing address is 3838 West Parkway Blvd, Salt Lake City UT, 84120. The company can be reached via phone at 801-954-7100 or via email at [email protected]
MarketBeat Community Rating for USANA Health Sciences (NYSE USNA)
MarketBeat's community ratings are surveys of what our community members think about USANA Health Sciences and other stocks. Vote "Outperform" if you believe USNA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe USNA will underperform the S&P 500 over the long term. You may vote once every thirty days.
